Document is current
Any future updates will be listed below
-
Authors
Zabala, Alexander http://orcid.org/0000-0001-5389-1271
Darsalia, Vladimer
Lind, Marcus
Svensson, Ann-Marie
Franzén, Stefan
Eliasson, Björn
Patrone, Cesare
Jonsson, Magnus
Nyström, Thomas
- License Information
-
More Information
Article History
Received: 29 June 2021
Accepted: 29 September 2021
First Online: 6 October 2021
Declarations
:
: All patients have consented to being reported in NDR. No individual consent is required for inclusion in this study, according to Swedish law. This nationwide registry based retrospective nationwide cohort study was approved by the regional ethics committee in Gothenburg, Sweden (EPN Dnr 776-14).
: Not applicable.
: TN has received unrestricted grants from AstraZeneca and NovoNordisk and has served on national advisory boards of Amgen, Novo Nordisk, Sanofi-Aventis, Eli Lilly, MSD and Boehringer Ingelheim. ML has received research grants from DexCom and Novonordisk and been consultant for Astra Zeneca, Boheringer Ingelheim, DexCom, Eli Lilly, MSD and Novonordisk.
